Abstract
Protein kinase C (PKC)-θ regulates conventional effector T (Teff) cell function. Since this initial finding, it has become clear that the role of PKC-θ in T cells is complex. PKC-θ plays a central role in Teff cell activation and survival, and negatively regulates stability of the immunological synapse (IS). Recent studies demonstrated that PKC-θ is required for the development of natural CD4 +Foxp3 + regulatory T (Treg) cells, and mediates negative regulation of Treg cell function. Here, we examine the role of PKC-θ in the IS, evidence for its distinct localization in Treg cells and the therapeutic implications of inhibiting PKC-θ in Teff cells, to reduce effector function, and in Treg cells, to increase suppressor function, for the prevention and treatment of autoimmune and alloimmune disease states.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 358-363 |
| Number of pages | 6 |
| Journal | Trends in Immunology |
| Volume | 32 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2011 |
Bibliographical note
Funding Information:NIH grants PN2EY016586 (MLD), R01 HL56067, and P01 CA067493 (BRB) and Leukemia and Lymphoma Translational Research (grant R6029-07) (BRB)
Fingerprint
Dive into the research topics of 'PKC-θ function at the immunological synapse: Prospects for therapeutic targeting'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS